Align Technology | ALGN - 销售收入

股票价格
157.25
每天变化
-3.28 -2.04%
每月一次
-15.01%
每年
-16.49%
Q2 预测
165.29


金融业
股票价格
USD
资产
USD 6.31B
现金及等价物
USD 1.06B
销售成本
USD 303.5M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 114.45M
EBIT
USD 178.05M
EBITDA
USD 260.87M
员工
20.95K
EPS每股收益
USD 2.58
股本和储备
USD 4.15B
销售毛利
USD 736.59M
债务利息支出
USD 16.05M
利息收入
USD 4.62M
贷款资金
USD 0
市值
USD 11.85B
净收入
USD 112.77M
营业费用
USD 862.03M
营业利润
USD 178.05M
普通股股本
USD 71.62M
PE价格收益
22.78
税前利润
USD 148.89M
销售收入
USD 1.04B
销售和管理费用
USD 465.34M
股票
USD 214.94M
贸易债权人
USD 123.72M
应收帐款人
USD 1.13B


销售 更改 日
3M USD 6B 100M 2026-03
Align Technology USD 1.04B 10M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Bruker USD 823.4M 153.8M 2026-03
Cardinal Health USD 60.9B 4.73B 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
CVS Health USD 100.4B 5.3B 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Dexcom USD 1.19B 70M 2026-03
Henry Schein USD 3.37B 30M 2026-03
Idexx Laboratories USD 1.14B 50M 2026-03
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
IQVIA Holdings USD 4.15B 210M 2026-03
Masimo USD 403.6M 8.9M 2026-03
McKesson USD 92.3B 13.86B 2026-03
Mettler Toledo International USD 947.13M 182.87M 2026-03
Revvity USD 711M 61.06M 2026-03
Solventum Corp USD 2.01B 20M 2026-03
Stryker USD 6B 1.2B 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Veeva Systems USD 835.95M 24.72M 2025-12
Waters USD 1.27B 338M 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03
Zoetis USD 2.3B 100M 2026-03